Published Paper
Published Papers:

Year Title Journal
2022 Effects of Para-Toluenesulfonamide on Canine Melanoma Xenotransplants in a BALB/c Nude Mouse Model Animals 2022, 12(17), 2272


Autophagic Activation and Decrease of Plasma Membrane
Cholesterol Contribute to Anticancer Activities in Non-Small Cell Lung Cancer

Molecules. 2021 Oct 1;26(19):5967


Effects of para-toluenesulfonamide intratumoral injection on pulmonary adenoid cystic carcinoma complicating with severe central airway obstruction: a 5-year follow-up study

 J Thorac Dis. 2018 Apr;10(4):2448-2455.

Para-Toluenesulfonamide Induces Anti-tumor Activity Through Akt-Dependent and –Independent mTOR/p70S6K Pathway: Roles of Lipid Raft and Cholesterol Contents

Front Pharmacol. 2018 Nov 13;9:1223.

Effects of para–toluenesulfonamide intratumoral injection on non-small cell lung carcinoma with severe central airway obstruction: A multi-center, non-randomized, single-arm, open-label trial

Lung Cancer. 2016 Aug;98:43-50.

Para-toluenesulfonamide induces tongue squamous cell carcinoma cell death through disturbing lysosomal stability

Anticancer Drugs . 2015 Nov;26(10):1026-33

Antitumor effect of para-toluenesulfonamide against lung cancer xenograft in a mouse model

J Thorac Dis 2013;5(4):472-483.

Puncture injection of para-toluenesulfonamide combined with chemoembolization for advanced hepatocellular carcinoma

World J Gastroenterol. 2012 Dec 14;18(46):6861-4.

Metabolism and effect of para-toluene-sulfonamide on rat liver microsomal cytochrome P450 from in vivo and in vitro studies

Acta Pharmacol Sin. 2006 May;27(5):635-40.

An evaluation of para toluene-sulfonamide metabolism and effect with regard to CYP isoforms, P-glycoprotein, and drug interactions

Pharmazie. 2006 Oct;61(10):869-73.